Clinical trial
Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary…
NCT00132912 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00132912 |
|---|---|
| Title | Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arterial Obstructive Diseases, Coronary Disease |
| Intervention type | Drug |
| Interventions | SCH 530348 |
| Enrollment | 1,030 |
| Start date | Aug 30, 2005 |
| Primary completion | Jan 28, 2007 |
| Completion | Jan 28, 2007 |
| First posted | Aug 22, 2005 |
| Last update posted | May 25, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: